Keratin 19 (KRT19) (Middle Region) Peptide
KRT19
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN2183650
Quick Overview for Keratin 19 (KRT19) (Middle Region) Peptide (ABIN2183650)
Target
Cytokeratin 19 (KRT19)
(Keratin 19 (KRT19))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-KRT19 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Background
-
KRT19 involved in the organization of myofibers. Together with KRT8, KRT19 helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Alias Symbols: CK19, K19, K1CS
Protein Size: 400 -
Molecular Weight
- 44 kDa
-
Gene ID
- 3880
-
NCBI Accession
- NM_002276, NP_002267
-
UniProt
- P08727
Target
-
You are here:
